Abby Yi
Abby Yi focuses her practice on representing a diverse range of companies in connection with internal and government investigations concerning white collar and corporate compliance matters. Abby represents companies and individuals in government investigations involving the Department of Justice, United States Attorneys’ Offices, Securities and Exchange Commission, and Department of Homeland Security regarding alleged violations of federal securities laws, Foreign Corrupt Practice Act, False Claims Act, and other criminal and civil regulations.
Abby has significant experience counseling clients on healthcare fraud and abuse issues. Abby regularly assists healthcare plans, risk-bearing provider groups, hospital systems, and vendors, with investigations and compliance reviews considering issues, including Medicare Advantage risk-adjustment coding, marketing practices, and kickback allegations, cybersecurity, and data privacy. Abby has a particular interest in use of data analytics and other forensic capabilities to develop facts in her investigations. Abby also defends healthcare companies respond to government enforcement actions involving potential False Claims Act violations before the Department of Justice, United States Attorneys’ Offices, and Department of Health and Human Services.
Memberships
Asian Pacific American Bar Association of the Greater Washington, D.C. Area (APABA-DC)
Korean American Bar Association for the Washington, D.C. Area (KABA-DC)
International Association of Korean Lawyers — D.C. Conference Host Committee Member (2016)
American Health Law Association (AHLA)
Representative Experience
-
Read More
Representation of a national healthcare company in an investigation related to allegations of fraudulent risk adjustment coding practices. Matter involved government disclosure and an analysis of data correction obligations.
-
Read More
Representation of a Medicare Advantage Organization in an investigation related to data-driven coding anomalies and practices detected at a large contracted provider group.
-
Read More
Representation of a Medicare Advantage Organization and its wholly-owned provider group in an internal investigation related to allegations of improper coding practices, hostile work environment, and non-compliance with Medicare requirements.
-
Read More
Representation of a Fortune 50 healthcare company in conducting oversight of network provider marketing practices and compliance with Medicare marketing regulations.
-
Read More
Representation of a Medicare Advantage plan in multiple internal investigations related to its grievance and appeal procedures.
-
Read More
Representation of a large national healthcare company in its defense of a FCA qui tam involving its wholly-owned Pharmacy Benefit Manager. After extensive negotiation, DOJ declined to intervene in the matter. The relator pursued the case independently, which resulted in a favorable resolution to our client.
-
Read More
Representation of a national managed care organization in an internal review of potentially improper home health and hospice discharge protocols.
-
Read More
Representation of a managed care organization in a review of whistleblower allegations related to the post-acquisition integration of a specialty pharmacy. The matter involved an assessment of risk specific to data privacy obligations.
-
Read More
Representation of a Fortune 50 healthcare company in its response to a third-party grand jury subpoena.
-
Read More
Representation of a Fortune 50 healthcare company in its response to a third-party grand jury subpoena.
Publications
Past Events
Media Mentions & Firm News
Accolades
FINRA Office of Fraud Detection and Market Intelligence — Winner, 2016 Case of the Year Award
American University Washington College of Law — Exceptional Pro Bono Public Service Award
